Announcements
15 May 2026
Cancers | 2025 Editor’s Choice Articles and Opening Special Issues Related to Cancer Drug Development
Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the Editor's Choice Articles and Special Issues related to Cancer Drug Development, a curated list of high-quality articles from 2025 in Cancers (ISSN: 2072-6694). The full list of Editor's Choice Articles can be viewed via the following link: https://www.mdpi.com/journal/cancers/editors_choice.
The list of relevant papers can be seen below:
“The Role of Canine Models of Human Cancer: Overcoming Drug Resistance Through a Transdisciplinary “One Health, One Medicine” Approach”
by Sara Gargiulo, Lidovina Vecchiarelli, Eleonora Pagni and Matteo Gramanzini
Cancers 2025, 17(12), 2025; https://doi.org/10.3390/cancers17122025
Available online: https://www.mdpi.com/2072-6694/17/12/2025
“Regulators of Cancer Progression: Succinylation”
by Jie Gao and Wei Yu
Cancers 2025, 17(16), 2652; https://doi.org/10.3390/cancers17162652
Available online: https://www.mdpi.com/2072-6694/17/16/2652
“Engineered Bifidobacterium Strains Colonization at Tumor Sites: A Novel Approach to the Delivery of Cancer Treatments”
by Rhea Amonkar, Ashley Ann Uy, Pablo Ramirez, Harina Patel, Jae Jin Jeong, Nicole Oyinade Shoyele, Vidhi Vaghela and Ashakumary Lakshmikuttyamma
Cancers 2025, 17(15), 2487; https://doi.org/10.3390/cancers17152487
Available online: https://www.mdpi.com/2072-6694/17/15/2487
“Toxicity Profiles of Antibody–Drug Conjugates: Synthesis and Graphical Insights to Optimize Patient-Centered Treatment Strategies for HER2-Negative Metastatic Breast Cancer”
by Bérénice Collineau, Anthony Gonçalves, Marie Domon, Damien Bruyat, François Bertucci and Alexandre de Nonneville
Cancers 2025, 17(14), 2307; https://doi.org/10.3390/cancers17142307
Available online: https://www.mdpi.com/2072-6694/17/14/2307
“Deciphering Nicotine-Driven Oncogenesis in Head and Neck Cancer: Integrative Transcriptomics and Drug Repurposing Insights”
by Guo-Rung You, Daniel Yu Chang, Hung-Han Huang, Yin-Ju Chen, Joseph T. Chang and Ann-Joy Cheng
Cancers 2025, 17(9), 1430; https://doi.org/10.3390/cancers17091430
Available online: https://www.mdpi.com/2072-6694/17/9/1430
Special Issues:
“Recent Updates and Future Perspectives on Anti-Cancer Agents”
Guest Editor: Dr. Santosh Kumar Singh
Submission deadline: 15 August 2026
“Novel Drugs for Treating Gynecologic Cancers: 2nd Edition”
Guest Editors: Prof. Dr. Tadahiro Shoji and Prof. Dr. Tadahiro Shoji
Submission deadline: 20 August 2026
“Development of Biomarkers and Antineoplastic Drugs in Solid Tumors”
Guest Editors: Dr. Rosa Falcone, Dr. Sofia Verkhovskaia and Dr. Michela Roberto
Submission deadline: 31 October 2026
“In Vitro and In Vivo Pharmacology for Glioma Drug Discovery”
Guest Editor: Dr. Anna Bielecka-Wajdman
Submission deadline: 30 November 2026
You are invited to view and submit relevant papers to the journal via the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office
